Biotechnology Vaccines

Whether your product is a novel cell or gene- based therapy or an established therapeutic protein, the driving forces are competition, flexibility and efficiency: competitive production of mature biotech products including the generic versions, flexibility to use existing capacity for new or modified products, and efficient pilot launch and small scale production for bringing new products to market. 

While this optimization can ensure rapid production for clinical trials and boost production capacity for one or more products, the underlying challenge remains the same cost effective production is required in order to bring biopharmaceutical therapies to the world. 

At Integrated Project Services (IPS) we are at the forefront of knowledge in this exciting journey and our project and customer portfolios represent global best practices and landmark facilities. We are leading when it comes to fast establishment of new facilities, but we are equally resourceful when your issue is optimizing existing facilities. Whether your facility requires de-bottlenecking for a high-titer process, transition from single to multiproduct capability, a global automation strategy for a multivendor skid installation or you simply need to establish a cost effective operation with novel process technologies, we deliver a competitive edge that provides increased productivity. 

Cost effective productivity is always a top priority, and whether it requires establishment of new facilities or improvement of existing production, Integrated Project Services (IPS) can deliver the optimum solution. 

Over the years, Integrated Project Services (IPS) has executed number of such Biotech Projects.